Screening for high risk human papilloma virus (HR-HPV) subtypes, among Sudanese patients with oral lesions

被引:2
|
作者
Babiker, Ali Yousif [1 ]
Eltom, Faris Margani [1 ]
Abdalaziz, Mohamed S. [1 ]
Rahmani, Arshad [2 ]
Abusail, Saadalnour [3 ]
Ahmed, Hussain Gadelkareem [4 ]
机构
[1] Sudan Univ Sci & Technol, Coll Med Labs Sci, Dept Histopathol & Cytol, Khartoum, Sudan
[2] Qassim Univ, Dept Med Lab Sci, Coll Appl Med Sci, Qasim, Saudi Arabia
[3] Elneelain Univ, Fac Med Lab Sci, Dept Histopathol & Cytol, Khartoum, Sudan
[4] Univ Khartoum, Fac Med Lab Sci, Dept Histopathol & Cytol, Khartoum, Sudan
关键词
Oral lesions; HR-HPV; PCR; Toombak; smoking; SQUAMOUS-CELL CARCINOMAS; NON-SNUFF-DIPPERS; OROPHARYNGEAL CANCER; HEAD; SCANDINAVIA; MUTATIONS; TOOMBAK; GENE;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
HR-HPV subtypes are strongly linked to etiology of many human cancers including oral cancer. The epidemiology of infection with different HPV genotypes greatly varies in different countries. The aim of this study was to identify and genotype the HR-HPV subtypes in oral tissues obtained from Sudanese patients with oral lesions. In this retrospective study 200 patients with oral lesions were screened by molecular methods (PCR) for the presence of HR-HPV subtypes. Of the 200 patients, 100/200 were patients with oral cancer (ascertained as case group) and 100/200 were patients with non-neoplastic oral lesions (ascertained as control group). Out of the 200 patients, 12/200 (6%) were found with HR-HPV infection. Of the 12 positive patients, 8/12 (66.7%) were among cases and the remaining 4/12 (33.3%) were among control group. The distribution of different genotypes was: type HPV 16 6/12 (50%), HPV18 4/12 (34%), HPV 31 1/12 (8%) and HPV 33 1/12 (8%). In view of these findings, HPV particularly subtypes 16 and 18 play a role in the etiology of oral cancer in the Sudan.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 50 条
  • [31] Should we test for high-risk human papilloma virus in patients with oral dysplasia?
    Higginson, James
    Nugent, Michael
    Robinson, Max
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2016, 54 (05): : 590 - 591
  • [32] Synthetic Vaccine for the Treatment of Lesions Caused by High Risk Human Papilloma Virus
    Melief, Cornelis J. M.
    CANCER JOURNAL, 2011, 17 (05): : 300 - 301
  • [33] HIGH-RISK HUMAN PAPILLOMAVIRUS (HR-HPV) DETECTION IN MEN WITH AND WITHOUT THE HISTORY OF CHLAMYDIA TRACHOMATIS INFECTION
    Smelov, V.
    Terekhov, V.
    Ouburg, S.
    Pleijster, J.
    Gorelov, A.
    Novikov, A.
    Morre, S.
    SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A290 - A291
  • [34] Detection of High-Risk Human Papillomavirus (hr-HPV) in Head and Neck Carcinoma Samples from Honduras
    Georgantzoglou, N.
    Alas-Pineda, C.
    Hershberger, K.
    MacKenzie, T.
    Suresh, A.
    Kennedy, L.
    Bejarano, S.
    Tsongalis, G.
    Kerr, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S69 - S69
  • [35] Human papilloma virus (HPV) infection in childhood: Can 'high-risk' HPVs be detected in benign skin lesions in children?
    Mammas, Ioannis N.
    Sourvinos, George
    Giamarelou, Panagiota
    Michael, Catherine
    Zaravinos, Apostolos
    Spandidos, Demetrios A.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S51 - S51
  • [36] The development of quality control panels for the high-risk human papilomavirus (HR-HPV) detection system.
    Wang, H.
    Mal, C.
    Zhou, Y.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [37] Age-related detection of 'high-risk' human papilloma virus (HPV) 16 in children's oral cavity
    Sourvinos, G.
    Mammas, I.
    Giamarellou, P.
    Michael, C.
    Spandidos, D. A.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S54 - S54
  • [38] DOUBLE DEMONSTRATION OF ONCOGENIC HIGH RISK HUMAN PAPILLOMA VIRUS DNA AND HPV-E7 PROTEIN IN ORAL CANCERS
    Pannone, G.
    Santoro, A.
    Carinci, F.
    Bufo, P.
    Papagerakis, S. M.
    Rubini, C.
    Campisi, G.
    Giovannelli, L.
    Contaldo, M.
    Serpico, R.
    Mazzotta, M.
    Lo Muzio, L.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 (02) : 95 - 101
  • [39] Mast cells in HG lesions of patients co-infected with human papilloma virus (HPV) and human immunodeficiency virus (HIV)
    Nelson, AM
    Man, YG
    LABORATORY INVESTIGATION, 2006, 86 : 257A - 257A
  • [40] Does the High Risk (HR) Human Papilloma Virus (HPV) RLU/CO ratio obtained in positive Hybrid Capture II RNA probing correlate with persistence of HPV and/or
    Lummus, Seth
    Gaido, Loretta
    Penick, Amanda
    Harper, Judy W.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A006 - A006